Venus Remedies

VENUSREM18 May 2024
Pharmaceuticals
+4.90 (+1.63%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Venus Remedies
Venus Remedies
Pharmaceuticals
VENUSREM18 May 2024
+4.90 (+1.63%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

Venus Remedies - Share Price & Details

Lowest Today
299.65
Highest Today
310.4
Today’s Open
299.65
Prev. Close
300.15
52 Week High
429.6
52 Week Low
192.3
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
52.45%
Upper Circuit
Lower Circuit
P/E TTM
15.98
P/B Ratio
0.84
Traded Value(Cr)
0.00
EPS TTM
19.09
Book value
Dividend
0.00%

Price Performance

3.20 %
1 Wk
-8.86 %
1 M
-12.98 %
3 M
52.45 %
1 Y
-24.79 %
YTD

Traded Volume Movement

Technical Details

Support 3
287
Support 2
293
Support 1
299
Pivot Point :
305
Resistance 1
311
Resistance 2
316
Resistance 3
323

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Venus Remedies Ltd
₹305.05(+4.90/1.63%)
305.05+4.90407.7652.4515.980.84
Astrazeneca Pharma India Ltd
₹5,757.35(-0.40/-0.01%)
5,757.35-0.4014,393.3878.5390.2421.98
Cipla Ltd
₹1,403.90(+4.55/0.33%)
1,403.90+4.55113,350.1853.5430.524.05
Bliss GVS Pharma Ltd
₹110.40(+0.85/0.78%)
110.40+0.851,155.7950.5515.251.17
Abbott India Ltd
₹26,643.70(+153.50/0.58%)
26,643.70+153.5056,617.8627.0947.1315.31
Amrutanjan Health Care Ltd
₹743.15(-0.35/-0.05%)
743.15-0.352,148.4923.4148.838.20

About Venus Remedies Ltd

Venus Remedies Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 407.76 crores. It has reported a sales of Rs. 131.23 crores and a net profit of Rs. 8.19 crores for the quarter ended December 2018. The company management includes Pawan Chaudhary, Pawan Chaudhary,Manu Chaudhary,Peeyush Jain,Ashutosh Jain,Gilbert Wenzel,S. K. Chadha,Neha Kodan,Navdeep Sud,Savita Gupta,Akshansh Chaudhary,Nps Monga (Venus Remedies Ltd) among others.
Chairman
Pawan Chaudhary
Registered office
S C No 857 Cabin No 10 2nd Flr,N A C Manimajra,Chandigarh,Chandigarh,160101
FAX :
Background
Incorporation Year1989
Face Value₹10
Market Lot1

Latest News

Trade setup for Tuesday: 15 things to know before opening bell
Before market opens on Tue, check these things:
📌Key Levels For The Nifty 50
📌Key Levels For The Bank Nifty
📌Nifty Call Options Data
📌Nifty Put Options Data
📌Bank Nifty Call Options Data
📌Bank Nifty Put Options Data
📌Put-Call Ratio
📌India VIX
📌Long Unwinding (31 Stocks)
📌 Short Build-up (30 Stocks)
📌Short-Covering (57 Stocks)
📌 High Delivery Trades
📌Stocks Under F&O Ban
20 May 2024 | 07:29 PM
Trade setup for Tuesday: 15 things to know before opening bell
Before market opens on Tue, check these things:
📌Key Levels For The Nifty 50
📌Key Levels For The Bank Nifty
📌Nifty Call Options Data
📌Nifty Put Options Data
📌Bank Nifty Call Options Data
📌Bank Nifty Put Options Data
📌Put-Call Ratio
📌India VIX
📌Long Unwinding (31 Stocks)
📌 Short Build-up (30 Stocks)
📌Short-Covering (57 Stocks)
📌High Delivery Trades
📌Stocks Under F&O Ban.
20 May 2024 | 07:29 PM
IRIS Business S Consolidated March 2024 Net Sales at Rs 30.35 crore
Reported Consolidated quarterly numbers for IRIS Business Services are:Net Sales at Rs 30.35 crore in March 2024 up 47.66% from Rs. 20.56 crore in March 2023.Quarterly Net Profit at Rs. 4.71 crore in March 2024 up 197.45% from Rs. 1.58 crore in March 2023.EBITDA stands at Rs. 6.66 crore in March 2024 up 96.46% from Rs. 3.39 crore in March 2023.
20 May 2024 | 11:55 PM
JB Pharma aims 12-14% revenue growth over next 2 years: CEO
JB Pharma, majority-owned by investment firm KKR & Co., aims to grow its revenue by 12-14% in the next couple of years with a thrust on domestic and contract development and manufacturing organization (CDMO) businesses, its chief executive Nikhil Chopra said. The company is also foraying into new geographies like Europe and Brazil through tie-ups and product launches.
20 May 2024 | 08:17 PM
Hindustan Aeronautics Consolidated March 2024 Net Sales at Rs 14,768.75 cr
Reported Consolidated quarterly numbers for Hindustan Aeronautics are: Net Sales at Rs 14,768.75 crore in March 2024 up 18.2% from Rs. 12,494.67 crore in March 2023.Quarterly Net Profit at Rs. 4,308.71 crore in March 2024 up 52.19% from Rs. 2,831.18 crore in March 2023. EBITDA stands at Rs. 6,458.57 crore in March 2024 up 62.77% from Rs. 3,968.02 crore in March 2023.
20 May 2024 | 08:02 PM

How to buy Venus Remedies shares on nse?

To buy Venus Remedies shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Venus Remedies share price today?

The Venus Remedies shares price on nse is Rs.305.05 today.

What is the market cap of Venus Remedies shares on BSE ?

The company has a market capitalization of Rs.407.76Cr

What is the PE & PB ratio of Venus Remedies shares ?

PE is 15.98 and PB is 0.84

What is the 52 Week High and Low of Venus Remedies shares?

Venus Remedies stock price high: Rs.429.6 Venus Remedies stock price low: Rs.192.3